Publication details

Acute effects of sigma receptor ligand haloperidol on electrogram and coronary flow in rat isolated heart

Investor logo
Authors

NOGOVÁ Kateřina NOVÁKOVÁ Marie

Year of publication 2008
Type Conference abstract
MU Faculty or unit

Faculty of Medicine

Citation
Description Mechanisms of life-threatening cardiovascular side effects of sigma receptor ligands (cardiac arrhythmias such as torsade de pointes, ventricular fibrillation or even cardiac arrest) are not fully elucidated yet. Therefore we examined the effects of their representative haloperidol on 3-D electrogram and mean coronary flow in isolated rat hearts. Eight adult male rats were sacrificed under deep ether anesthesia. The hearts were perfused according to Langendorff with Krebs-Henseleit solution (K-H) at constant pressure (85mmHg) and 37C (CaCl2, 1.2 mM). The experiment consists of four 30min periods: control, 10nM haloperidol, washout, 10nM haloperidol. Ten successive RR intervals were averaged at the end of control (steady state heart rate). This value was used for normalization of heart rate during the rest of experiment. In the same way, QT intervals were examined in order to determine L-QT. The incidence of arrhythmias was assessed according to Lambeth Conventions. Coronary flow was measured every 5th minute. Normalized spontaneous heart rate showed a clear tendency to decrease during both haloperidol applications and this effect was partially reversible. In all hearts, the QT intervals lengthened in the first haloperidol period, partially restored in washout and in the second haloperidol administration QT interval remained unchanged. No significant incidence of life-threatening arrhythmias was observed, except of premature ventricular complexes (occurring as singles, salvos or tachycardia). Three hearts were classified by number 3. The changes of coronary flow were inconsistent and insignificant. In conclusion, QT prolongation observed in our experimental model can explain the occurrence of arrhythmias. No change of QT interval in the second haloperidol application can be reasoned by down-regulation of cardiac sigma receptor.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.

More info